Related Experiment Videos
Thalidomide in 42 patients with prurigo nodularis Hyde
Tina P Andersen1, Karsten Fogh
1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Dermatology (Basel, Switzerland)
|September 29, 2011
Summary
Thalidomide effectively treats prurigo nodularis Hyde (PNH) that is resistant to standard therapies. However, potential side effects like peripheral neuropathy and sedation necessitate careful physician monitoring.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Prurigo nodularis Hyde (PNH) is a chronic inflammatory skin condition.
- PNH often presents with severe itching and excoriated nodules, significantly impacting quality of life.
- Standard treatments for PNH can be ineffective or poorly tolerated by some patients.
Purpose of the Study:
- To evaluate the efficacy and safety of thalidomide for treating PNH.
- To describe the treatment outcomes in patients with refractory PNH or those intolerant to other therapies.
Main Methods:
- Retrospective review of 77 medical records.
- Analysis of patient demographics, disease characteristics, treatment details, and outcomes.
- Focus on patients with PNH treated with thalidomide.
Main Results:
- 54 patients had PNH, all refractory to or intolerant of standard treatments.
- 42 patients received thalidomide, with the majority experiencing clinical improvement.
- Common reasons for discontinuing thalidomide were side effects, primarily peripheral neuropathy and sedation.
Conclusions:
- Thalidomide is an effective treatment option for prurigo nodularis Hyde (PNH) refractory to standard therapies.
- Physicians must carefully consider and monitor for potential side effects, particularly peripheral neuropathy and sedation.
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...